Back to search
FDAFDA · Food and drugs·Recall number D-0919-2017

ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327

Published June 21, 2017 · Recall initiated: April 17, 2017

Summary

FDA records drug Class II recall D-0919-2017, published June 21, 2017 and initiated April 17, 2017. Recalling firm: American Pharmaceutical Ingredients LLC; Status: Terminated; Reported quantity: 1g=1 bottle; 5g=4 bottle; 25g=3 bottles; Lot: Lots: 052915-1, 052915-2, exp 5/5/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations; lack of quality assurance.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Pharmaceutical Ingredients LLC
Distributor
NY, GA, NV, CA, KY, TX
Lot
Lots: 052915-1, 052915-2, exp 5/5/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327 recalled?

Yes. FDA published recall D-0919-2017 on June 21, 2017. Reported hazard: cGMP Deviations; lack of quality assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit